Amniotic Membrane Market

Global Amniotic Membrane Market Size (2024 to 2032)

The size of the global amniotic membrane market was worth USD 858 million in 2023. The global market is anticipated to grow at a CAGR of 12.16% from 2024 to 2032 and be worth USD 2,411 million by 2032 from USD 963 million in 2024.

The amniotic membrane is the outer layer that surrounds and protects the embryo. It is also the innermost layer of the placenta and consists of a thick basement layer enclosing the amniotic cavity. It is a surgical biomaterial, even replacing the skin in pathological conditions, including plastic surgery and wound healing. The amniotic membrane applications include the genitourinary tract, Ophthalmology, brain, skin, neck, head, and other surgical procedures. For example, at Rambam Health Care Campus, Israeli doctors in Haifa have recently conducted a successful surgery where a woman’s eyesight has been restored using a placenta membrane transplant.

MARKET DRIVERS

The growing awareness of the benefits associated with amniotic membranes propels global amniotic membrane market growth.

Increasing hazardous trauma cases, burn cases, surgical cures, and growing awareness of amniotic membrane products are driving the amniotic membrane market. In addition, rising numbers of cosmetic surgery cases have also contributed favorably towards increasing the market growth and, subsequently, adopting its services. Furthermore, the growing efforts on R&D activities, increasing investments from the private sector to conduct R&D, and YOY growth in the number of surgeries performed worldwide are expected to fuel the market’s growth rate.

The global amniotic membrane market has extensively benefitted from rapid growth in the geriatric population, the increasing amniotic membrane transplantations, and focused research activities worldwide, which increase awareness about the advantages of amniotic membrane transplants. Therefore, the new players with considerable investments in the development of the amniotic membrane market are significant parts of the market's growth in the upcoming years. In addition, the growth of updated technological developments, the growing population, and the rising amniotic membrane transplants support the amniotic membrane market. 

MARKET RESTRAINTS

High costs associated with therapies and the scarcity of experienced and skilled professionals hinder the global amniotic membrane market growth.

The globally increasing amniotic membrane-based surgeries expected the growth of the amniotic membrane market. The professionals do these surgeries, so the shortage of that skilled surgeons can hamper the regional and global markets. Rising healthcare costs do not affect market growth. The research interest shown by medically advanced communities and institutions in novel regenerative medicines and possibly stem cell applications are opportunities for the amniotic membrane market.

REPORT COVERAGE

SEGMENTAL ANALYSIS

Global Amniotic Membrane Market Analysis By Product

Based on product type, the cryopreservation amniotic membranes lead the market and predict to reach USD 1,090.08 million by the end of the forecast period. Cryopreservation involves storing the amniotic membrane with all its histological and biological properties intact. The preservation is done by using a glycerol mixed solution and storing at -80 degree Celsius; therefore, the amniotic membranes stored like this are of high quality and can be used for visual surgery aids. 

However, the lyophilized amniotic membranes showcase the highest CAGR of 14.18% during the forecast period. Furthermore, the amniotic membrane extract can treat ophthalmic defects in the corneal epithelia. This innovative product's development was based on the lyophilized human amniotic membrane, which allowed the current application to the optical surface of unlimited quantities of amniotic membrane biological factors.

Global Amniotic Membrane Market Analysis By Application

Based on the application, the surgical wounds segment held the most significant market shares in the global market in 2023. The growing interests in surgical cures, increasing cases of hazardous trauma, burns, cosmetic surgery, and upcoming Amniotic Membrane applications are definite plus points toward the market's growth.

However, the ophthalmology segment is expected to have a promising CAGR during the forecast period due to the elasticity, transparency, and thin material of amniotic membranes that make them suitable for eye surgeries and patch-ups. 

Global Amniotic Membrane Market Analysis By End-User

Based on the end-user, the hospital segment is expected to dominate the amniotic membrane market during the forecast period owing to the frequent influx of patients in the hospital sectors and the wide range of infrastructure and availability of professional surgeons. Additionally, the different surgeries scheduled in healthcare settings daily drive the demand for the segment. 

However, specialized clinics like plastic surgery, dermatology, ophthalmology centers, etc., also require the assistance of amniotic membranes at regular intervals to promote market growth. Additionally, the growing investments in the research and development segment are also expected to help the rise of the market revenue.

REGIONAL ANALYSIS

The Americas currently hold the largest market share, whereas Asia-Pacific has the most significant growth rate. In particular, the North American region is leading the global amniotic membrane market. The market growth in this region is rising because of factors like the rise in the number of attempted surgeries, the increase in the biotechnology and pharmaceutical sector, improved healthcare facilities, and growth in medical device manufacturers. 

The European region is expected to have significant growth during the forecast period due to the adoption of better healthcare systems built according to universal standards and supported by funding from government organizations promoting growth for the region. Additionally, the growing cases of chronic conditions like cardiovascular diseases, cancer, diabetes, etc., among the populations of countries like the U.K., Italy, France, Germany, etc., are leading to demand for advanced technologies and the adoption of amniotic membrane applications in healthcare. 

The Asia Pacific region is growing equivalent to North America. Therefore, the Asia Pacific region market for the amniotic membrane will develop radically. The Asia Pacific market is expected to grow with the rise in the patient population and the augments in healthcare spending. Europe is also contributing a fair market share in the revenue. Mainly the Indian market exhibits the highest growth rate of 13.60% during the forecast period.

KEY MARKET PLAYERS

A few of the notable companies leading the global amniotic membrane market profiled in this report are Applied Biologics (United States), Alliqua BioMedical Inc. (United States), Integra Lifesciences (United States), Skye Biologics Inc. (United States), MiMedx (United States), Amniox Medical Inc. (United States), Katena Products Inc. (United States), Human Regenerative Technologies LLC (United States), Amnio Technology LLC (United States) and Osiris Therapeutics Inc. (United States).

RECENT HAPPENINGS IN THE MARKET

• In December 2022, Celularity Inc., a clinical-stage biotechnology company developing placenta-derived allogenic cell therapies and biomaterial products, declared today that its business models, commercial-stage biomaterial products, and clinical and investigational stage cellular therapeutic programs have all received Halal Certification, indicating that they have undergone thorough evaluation to determine that they are permissible or acceptable. The certificates allowed the company to cater to Islamic markets all over the world and were granted by Circle H International, Inc. ("Circle H"). This announcement supports Celularity's plan to expand internationally, which will eventually see the company establish a presence in the Middle East North Africa (MENA) area and give Saudi Arabia priority.
• In December 2022, Sanara MedTech will be a high-growth microcap company revolutionizing the wound and skin care industries. A small-cap health technology business with big-cap potential. A management group that shares mutual trust and has a clear vision and sense of ownership in its operations. Twenty-three items and services in their strong pipeline sell better than expected (124% yearly growth).
• In November 2022, Amniotic fluid was shown to be effective in treating various human diseases and disorders, according to a review recently published in the international scientific journal Biomedicines. For example, according to the article, complicated wounds like burn wounds and diabetic foot ulcers have been successfully treated with cfAF. By encouraging angiogenesis, the process of creating new blood vessels, the therapy can speed up the healing of wounds.

DETAILED SEGMENTATION OF THE GLOBAL AMNIOTIC MEMBRANE MARKET INCLUDED IN THIS REPORT

This research report on the global amniotic membrane market has been segmented and sub-segmented based on the product, application, end-user, and region.

By Product

• Cryopreserved
• Lyophilization

By Application

• Surgical Wounds
• Ophthalmology
• Stem Cell Biology
• Regenerative Medicine
• Others

By End-User

• Hospitals
• Ambulatory Surgical Centers
• Specialized Clinics
• Research Centers & Laboratory

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa